Valion Bio (VBIO) EBT Growth (1y) (2022 - 2026)
Valion Bio (VBIO) EBT Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 8.48% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.60% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 88.57% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.23% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 213.87% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 530.43% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 96.45% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -12.04% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -182.24% |
| 10 | Valion Bio | 420,133.64 | -1.78 Mn | -45,000.00 | 97.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -707.39% |
| Dec 31, 2025 | 104.83% |
| Sep 30, 2025 | -73.24% |
| Jun 30, 2025 | -45.85% |
| Mar 31, 2025 | 1.70% |
| Dec 31, 2024 | 34.23% |
| Sep 30, 2024 | 20.98% |
| Jun 30, 2024 | 39.09% |
| Mar 31, 2024 | 29.27% |
| Dec 31, 2023 | 0.48% |
| Sep 30, 2023 | 31.25% |
| Jun 30, 2023 | 29.04% |
| Mar 31, 2023 | 15.42% |
| Dec 31, 2022 | -0.65% |
| Sep 30, 2022 | -114.32% |
| Jun 30, 2022 | -140.06% |
| Mar 31, 2022 | -88.86% |